Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.14 EUR | +1.65% |
|
+9.04% | +16.88% |
07-03 | FORVIA : Target upgrade by 14.5% | ![]() |
07-02 | UBS Raises European Auto Production Forecasts on Less-than-Feared US Tariff Impact | MT |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 14.65B | 15.62B | 25.46B | 27.25B | 26.97B | |||||
Total Revenues | 14.65B | 15.62B | 25.46B | 27.25B | 26.97B | |||||
Cost of Goods Sold, Total | 13.18B | 13.73B | 22.23B | 23.59B | 23.37B | |||||
Gross Profit | 1.47B | 1.88B | 3.22B | 3.66B | 3.6B | |||||
Selling General & Admin Expenses, Total | 732M | 695M | 1.22B | 1.29B | 1.29B | |||||
R&D Expenses | 342M | 331M | 897M | 953M | 935M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 91.7M | 92.6M | 219M | 193M | 190M | |||||
Other Operating Expenses, Total | 1.17B | 1.12B | 2.34B | 2.44B | 2.42B | |||||
Operating Income | 309M | 765M | 885M | 1.22B | 1.19B | |||||
Interest Expense, Total | -204M | -239M | -385M | -586M | -625M | |||||
Interest And Investment Income | 18.1M | 32M | 51.6M | 90.7M | 129M | |||||
Net Interest Expenses | -186M | -207M | -334M | -496M | -495M | |||||
Income (Loss) On Equity Invest. | -12.8M | -24.6M | 11.4M | -2.2M | -17.7M | |||||
Currency Exchange Gains (Loss) | -8.1M | -1.1M | -44.9M | -43.3M | -32M | |||||
Other Non Operating Income (Expenses) | -17.3M | -18.7M | -57.6M | 134M | -900K | |||||
EBT, Excl. Unusual Items | 84.3M | 513M | 460M | 816M | 642M | |||||
Restructuring Charges | -286M | -196M | -352M | -171M | -362M | |||||
Merger & Related Restructuring Charges | - | -37M | -77.3M | - | - | |||||
Impairment of Goodwill | -150M | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | |||||
Asset Writedown | -16.5M | - | - | 1.8M | 200K | |||||
Legal Settlements | - | - | - | - | 25.7M | |||||
Other Unusual Items | 170M | -28.1M | -95.2M | -43.9M | -94.9M | |||||
EBT, Incl. Unusual Items | -198M | 252M | -64.1M | 603M | 211M | |||||
Income Tax Expense | 123M | 139M | 186M | 232M | 235M | |||||
Earnings From Continuing Operations | -322M | 113M | -250M | 371M | -24.2M | |||||
Earnings Of Discontinued Operations | - | -96.5M | - | -5.4M | - | |||||
Net Income to Company | -322M | 16.2M | -250M | 366M | -24.2M | |||||
Minority Interest | -57.3M | -95M | -131M | -143M | -161M | |||||
Net Income - (IS) | -379M | -78.8M | -382M | 222M | -185M | |||||
Net Income to Common Incl Extra Items | -379M | -78.8M | -382M | 222M | -185M | |||||
Net Income to Common Excl. Extra Items | -379M | 17.7M | -382M | 228M | -185M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -2.75 | -0.57 | -2.2 | 1.13 | -0.94 | |||||
Basic EPS - Continuing Operations | -2.75 | 0.13 | -2.2 | 1.15 | -0.94 | |||||
Basic Weighted Average Shares Outstanding | 138M | 138M | 174M | 197M | 197M | |||||
Net EPS - Diluted | -2.75 | -0.57 | -2.2 | 1.12 | -0.94 | |||||
Diluted EPS - Continuing Operations | -2.75 | 0.13 | -2.2 | 1.15 | -0.94 | |||||
Diluted Weighted Average Shares Outstanding | 138M | 138M | 174M | 198M | 197M | |||||
Normalized Basic EPS | -0.03 | 1.64 | 0.9 | 1.86 | 1.22 | |||||
Normalized Diluted EPS | -0.03 | 1.64 | 0.9 | 1.86 | 1.22 | |||||
Dividend Per Share | 1 | - | - | 0.5 | - | |||||
Payout Ratio | - | -171.07 | - | - | -53.02 | |||||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 875M | 1.32B | 1.73B | 2.31B | 2.3B | |||||
EBITA | 400M | 857M | 885M | 1.46B | 1.42B | |||||
EBIT | 309M | 765M | 885M | 1.22B | 1.19B | |||||
Effective Tax Rate - (Ratio) | -62.29 | 55.19 | -290.64 | 38.52 | 111.46 | |||||
Total Current Taxes | 181M | 234M | 368M | 414M | 382M | |||||
Total Deferred Taxes | -57.8M | -95M | -181M | -182M | -147M | |||||
Normalized Net Income | -4.61M | 226M | 156M | 367M | 240M | |||||
Interest on Long-Term Debt | 48.4M | 45.5M | 53.9M | 58.8M | 57.4M | |||||
Non-Cash Pension Expense | 5.3M | -100K | 7.2M | 22.1M | 19.2M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 852M | 838M | 1.58B | 1.67B | 1.68B | |||||
Stock-Based Comp., Other (Total) | 15.8M | 3.9M | 16.4M | - | 13.9M | |||||
Total Stock-Based Compensation | 15.8M | 3.9M | 16.4M | - | 13.9M |
- Stock Market
- Equities
- FRVIA Stock
- Financials Forvia (ex-Faurecia)
- Income Statement
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition